Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting | C92 - Global Infectious Diseases

Tuesday 04/05/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Farrah J. Mateen, MD, PhD, FAAN
Infectious Disease, Global Health and Neuroepidemiology
Participants will get an overview of neurologic infections from the global perspective; neurological infections seen in US neurology practices, including emerging techniques to identify pathogen; and review clinical updates, scientific advances, and best practices for diagnosing and treating selected neurologic infections.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:15 AM PDT Introduction Introduction to Global Infectious Diseases
Farrah J. Mateen, MD, PhD, FAAN
07:00 AM - 07:00 AM PDT Speaker Walk-in Slides
Farrah J. Mateen, MD, PhD, FAAN
07:15 AM - 07:45 AM PDT Speaker No Time to Die: Around the World in Nine Neurological Infections
Farrah J. Mateen, MD, PhD, FAAN
07:45 AM - 08:15 AM PDT Speaker Casino Royale: International Mysteries in Emerging Infections
Michael R. Wilson, MD, FAAN
08:15 AM - 08:45 AM PDT Speaker You Only Live Twice: Advances in Neurological Infectious Disease Care
Monica M. Diaz, MD
08:45 AM - 09:00 AM PDT Q&A Questions and Answers
Michael R. Wilson, MD, FAAN, Farrah J. Mateen, MD, PhD, FAAN, Monica M. Diaz, MD
Faculty Disclosures
Farrah J. Mateen, MD, PhD, FAAN Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from EMD Serono. The institution of Dr. Mateen has received research support from Novartis. The institution of Dr. Mateen has received research support from Horizon Therapeutics.
Michael R. Wilson, MD, FAAN Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from UCSF Weill Institute for Neurosciences. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice.
Monica M. Diaz, MD The institution of Dr. Diaz has received research support from Alzheimer's Association. The institution of Dr. Diaz has received research support from American Academy of Neurology. The institution of Dr. Diaz has received research support from Merck. The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund.